# Effects of Medical Treatment of ICAS With Hemodynamic Disorders Based on MR-FFR

> **NCT06196398** · — · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 400 (estimated)

## Conditions studied

- Stroke, Ischemic
- Intracranial Atherosclerosis

## Interventions

- **DRUG:** Standard Medical Treatment on the basis of anti-platelet therapy

## Key facts

- **NCT ID:** NCT06196398
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196398, "Effects of Medical Treatment of ICAS With Hemodynamic Disorders Based on MR-FFR". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06196398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*